1 / 13

Peptic Ulcer Drugs Market

Peptic Ulcer Drugs Market, By Product Type (Proton Pump Inhibitors, Potassium-Competitive Acid Blocker (P-CAB), Antacids, H2- Antagonists, Antibiotics, Ulcer Protective), By Disease Indication (Gastritis, Gastric Ulcer, Duodenal Ulcer, Gastroesophageal Reflux Disease (GERD)), By Distribution Channel (Hospital Pharmacies, Private Clinics, Drug Stores, Retail Pharmacies, E-Commerce), By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027<br>

amshrihari
Télécharger la présentation

Peptic Ulcer Drugs Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Coherent Market Insights Market Research and Business Consulting Services https://www.coherentmarketinsights.com COVID-19 Impact Tracker

  2. PEPTIC ULCER DRUGS MARKET ANALYSIS Peptic Ulcer Drugs Market, By Product Type (Proton Pump Inhibitors, Potassium-Competitive Acid Blocker (P-CAB), Antacids, H2- Antagonists, Antibiotics, Ulcer Protective), By Disease Indication (Gastritis, Gastric Ulcer, Duodenal Ulcer, Gastroesophageal Reflux Disease (GERD)), By Distribution Channel (Hospital Pharmacies, Private Clinics, Drug Stores, Retail Pharmacies, E-Commerce), By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

  3. Peptic Ulcer Drugs Market – Insights Peptic ulcers are open sores that develop on the inside lining of the stomach and the upper portion of the small intestine. There are two types of peptic ulcers that include gastric ulcers and duodenal ulcers. Peptic ulcer disease (PUD) is a result of reduction in the thick layer of mucus that protects the stomach from digestive juices.

  4. Global Peptic Ulcer Drugs Market: Drivers Increasing prevalence of peptic ulcers is a major factor boosting growth of the global peptic ulcer drugs market over the forecast period. For instance, according to the study, ‘A36 The Global Incidence of Peptic Ulcer Disease and Its Complications at The Turn Of The 21st Century: A Systematic Review’, published in the Journal of the Canadian Association of Gastroenterology in March 2018, Spain recorded the highest annual incidence of all PUD (complicated and uncomplicated) with 141.8 cases per 100,000 persons.

  5. Global Peptic Ulcer Drugs Market Value (US$ Mn), by Region, 2018

  6. Global Peptic Ulcer Drugs Market: Restraints • Prolonged use of peptic ulcer drugs such as proton pump inhibitors and antibiotics may lead to increased risk of hip bone fracture as the ability to absorb calcium and iron decreases. Other side effects include, risk of opportunistic infections with S. pneumonia and C. defficile, owing to diminished natural gut flora. Such scenario is expected to hamper growth of the global peptic ulcer drugs market.

  7. Global Peptic Ulcer Drugs Market: Opportunities • Key players in the market can focus on personalized treatment and management of patients suffering from PUD in order to enhance their market share. For instance, in July 2019, in a study published in the Journal of Clinical Medicine (MDPI), researchers from Institute of Medical Microbiology, Switzerland, concluded that next generation sequencing technology may facilitate rapid monitoring of virulence determinants in H. pylori, which may prove beneficial in personalized treatment and management of patients suffering from PUD.

  8. Market Trends/Key Takeaways • The use of AI in diagnosis of peptic ulcers is a major trend in the global peptic ulcer drugs market. For instance, in December 2019, Inspirata, a US-based cancer informatics and digital pathology provider, partnered with DeePathology on Artificial Intelligence (AI)-based Helicobacter Pylori (H Pylori) pathology testing.

  9. Global Peptic Ulcer Drugs Market: Competitive Landscape • Major players operating in the global peptic ulcer drugs market include, Daewoong Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., Pfizer Inc., Abbott Laboratories, AstraZeneca plc., RedHill Biopharma, Cadila Healthcare Ltd., Novitium Pharma LLC, BoehringerIngelheim GmbH, Eisai Co. Ltd., Yuhan Corporation, and GlaxoSmithKline plc.

  10. Request Sample Report • Download PDF Brochure • Request Customization • Talk to Analyst BUY NOW For Your Reference: https://www.coherentmarketinsights.com/press-release/peptic-ulcer-drugs-market-2615

  11. About Us Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. What we provide: • Customized Market Research Services • Industry Analysis Services • Business Consulting Services • Market Intelligence Services • Long term Engagement Model • Country Specific Analysis

  12. Contact Us Mr. Shah Coherent Market Insights Private Ltd. Address: 1001 4th Ave, #3200 Seattle, WA 98154, U.S. Phone: +1-206-701-6702 Email: sales@coherentmarketinsights.com

  13. Thank You! Kindly follow CMI Social Media Profiles for the latest company updates FacebookLinkedIn Twitter https://www.coherentmarketinsights.com/

More Related